Sergio Pagliarini was first appointed Consultant Ophthalmic Surgeon in 2000 at Queen’s Medical Centre, Nottingham and then moved to University Hospitals Coventry and Warwickshire in 2001.
He has been a full-time ophthalmologist since 1990. He graduated with honours in medicine and obtained his specialist certificate in Ophthalmology in Italy. He then spent two years of clinical and research fellowships in Medical Retina at Moorfields Eye Hospital and St Thomas' Hospital focusing on age-related macular degeneration research. Thereafter, he continued doing clinical research at the University of Rome. He has been permanently based in the UK since 1995.
He practices all aspects of ophthalmology with a specialist interest in macular degeneration, treatment of macular and retinal diseases and microincision cataract surgery.
He has received several clinical excellence awards. He was nominated for Macular Society Clinical Services National Awards in 2001, 2012 and 2013.
He conceptualised and opened a state-of-the-art Macular Unit in 2011 at the Hospital of St. Cross, Rugby, attracting multicentre clinical research in macular disease and providing an environment for pioneering new diagnostic imaging.
Mr Pagliarini’s membership and contribution to international retinal imaging panels over the years distinctively fortified his skills in correctly diagnosing retinal diseases and monitoring intraocular injection treatments, putting him in a position of attracting referrals from his colleagues.
- Macular degeneration, dry and wet
- Microincision cataract surgery
- Retinal laser therapy
- Photodynamic therapy
- Central serous chorioretinopathy
- Diabetes and retinal vein occlusions
- Diagnostic retinal imaging (OCT retinal scans, Fundus autofluorescence)
- Fluorescein angiography and indocyanine green angiography
Sailing, Sea Kayaking, Photography, History
Treatments and tests offered by Mr Sergio Pagliarini at Nuffield Health
- Visual Fields
- Cataract Surgery
- Anterior resection
Mr Pagliarini is the Principal Investigator of over 12 research trials on macular degeneration or other macular and retinal diseases.
The NIHR, National Institute for Health Research awarded him a national Certificate of Recognition for outstanding research growth in ophthalmology on 12/03/2014.
He has published over 30 articles in scientific journals on macular degeneration and retinal diseases and has taken part in extreme environment research at the top of the Mount Rosa glacier in Italy, at 4,600m altitude.
- General Medical Council
- Specialist Register for Ophthalmology
- Fellow of the Royal College of Surgeons of Edinburgh
- Fellow of the Royal College of Ophthalmologists of England
- British Medical Association
- Medical Defence Union
- European Society of Cataract and Refractive Surgery
- American Academy of Ophthalmology
- Association for Research in Vision and Ophthalmology
- European Society of Retinal Specialists
Other posts held
- Consultant Ophthalmic Surgeon at University Hospitals Coventry and Warwickshire NHS Trust
Insurers Mr Sergio Pagliarini works with
Mr Sergio Pagliarini works with the following private medical insurance providers:
- Aviva Health
- AXA - Global Healthcare
- AXA Health
- Benenden Health
- CS Healthcare
- Exeter Family Friendly
- Vitality Health (Pru Health)
- Westfield Health WPA
Mr Sergio Pagliarini does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Mr Sergio Pagliarini has the following interest in equipment used at this hospital or another Nuffield Health hospital:
Heidelberg Retinal Angiograph (HRA) to carry out Scanning Laser Ophthalmosocopy imaging inclusive of fundus autofluorescence and retinal angiography. This is owned by Mr Pagliarini who set it up to provide to all Consultant Ophthalmologists at Nuffield Health Warwickshire Hospital a facility that yields superior and very high standard multimodality retinal imaging that it is seldom available in the private sector.
Mr Sergio Pagliarini does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.